Sign in

Arman Rakhar

Research Analyst at Barclays PLC

Arman Rakhar is an Equity Research Analyst at Barclays, specializing in coverage of the UK insurance and diversified financials sectors with a particular focus on leading names such as Prudential, Legal & General, and Aviva. His analytical work has been recognized for its depth and impactful investment recommendations, contributing to consistently above-benchmark returns and earning him high ratings among institutional clients. Arman began his research career at Barclays in 2019 following earlier positions in financial services and consulting, leveraging his expertise to deliver uniquely accurate sector insights. He holds several professional credentials including FINRA Series 7 and 63 registrations, solidifying his standing as a trusted advisor within the investment community.

Arman Rakhar's questions to NatWest Group (NWG) leadership

Question · Q3 2025

Arman Rakhar of Barclays sought insights into the key drivers for NatWest's income in 2026, including margin developments, loan growth, and fee income. He also inquired about the longer-term targets for 2028, specifically regarding structural operating leverage and the potential for Return on Tangible Equity (RoTE) accretion beyond the current 18%.

Answer

CFO Katie Murray outlined expectations for continued income growth into 2026, driven by strong multi-year loan growth, the structural hedge contributing over £1 billion more in 2025, and sustained non-interest income performance. CEO Paul Thwaite affirmed confidence in strong operating leverage, citing a 5% cost-income ratio improvement and over 9% jaws for the year, which will inform the 2028 targets to be shared in February.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts